Osteoporosis, osteopenia, and atherosclerotic vascular disease

Archives of Medical Science

Volumn 7, Issue 1, 2011, Pages 21-26

  Aronow, Wilbert S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Atherosclerotic vascular disease; Bone mineral density; Coronary artery disease; Myocardial ischemia; Osteopenia; Osteoporosis

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA VALVE DISEASE; ARTERY CALCIFICATION; ATHEROSCLEROSIS; BONE DENSITY; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; EXERCISE; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; OSTEOPENIA; OSTEOPOROSIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; REVIEW;

EID: 79952509659     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2011.20599     Document Type: Review

References (45)

1. World Health Organization. Guidelines for Preclinical Evaluation and Clinical Trials in Osteoporosis. World Health Organization, Geneva 1998.
2. Gupta G, Aronow WS. Atherosclerotic disease may be associated with osteoporosis or osteopenia in postmenopausal women: a preliminary study. Arch Gerontol Geriatr 2006; 43: 285-8. (Pubitemid 44233705)
3. Preventive Services Task Force. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 2002; 137: 526-8.
4. National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington 2003.
5. Lai HM, Aronow WS, Rachdev A, et al. Incidence of mortality in 1,040 patients with coronary heart disease or hypertensive heart disease with normal and abnormal left ventricular ejection fraction and with normal and abnormal QRS duration. Arch Med Sci 2008; 4: 140-2.
6. Kannam H, Aronow WS, Chilappa K, et al. Association of the QRS duration on the resting electrocardiogram with the severity of coronary artery disease in 2,196 patients undergoing coronary angiography for suspected coronary artery disease. Arch Med Sci 2009; 5: 163-5.
7. Lleva P, Aronow WS, Amin H, et al. Prevalence of electrocardiographic abnormalities in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Arch Med Sci 2008; 4: 259-62.
8. Amin H, Aronow WS, Lleva P, et al. Prevalence of transthoracic echocardiographic abnormalities in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Arch Med Sci 2010; 6: 40-2.
9. Ness J, Aronow WS. Comparison of prevalence of atherosclerotic vascular disease in postmenopaual women with osteoporosis or osteopenia versus without osteoporosis or osteopenia. Am J Cardiol 2006; 97: 1427-8.
10. Sennerby U, Melhus H, Gedeborg R, et al. Cardiovascular diseases and risk of hip fracture. JAMA 2009; 302: 1666-73.
11. Magnus JH, Brussard DL. Relationship between bone mineral density and myocardial infarction in US adults. Osteoporosis Int 2005; 16: 2053-62. (Pubitemid 41790927)
12. Barengolts EI, Berman M, Kukreja SC, et al. Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int 1998; 62: 209-13. (Pubitemid 28127932)
13. Broussard DL, Magnus JH. Coronary heart disease risk and bone mineral density among U.S. women and men. J Women's Health 2008; 17: 479-90. (Pubitemid 351457847)
14. Marcovitz PA, Tran HH, Franklin BA, et al. Usefulness of bone mineral density to predict significant coronary artery disease. Am J Cardiol 2005; 96: 1059-63. (Pubitemid 41416595)
15. Varma R, Aronow WS, Basis Y, et al. Relation of bone mineral density to frequency of coronary heart disease. Am J Cardiol 2008; 101: 1103-4.
16. Genant HK, Cooper C, Reid I, et al. Interim report and recommendations of the World Health organization Task force for Osteoporosis. Osteoporosis Int 1999; 10: 259-64.
17. Erbilen E, Yazici S, Ozhan H, et al. Relationship between angiographically documented coronary artery disease and low bone mass in men. Circ J 2007; 7: 1095-8. (Pubitemid 46998026)
18. Weber GF, Ashkar S, Glimcher MJ, Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996; 271: 509-12. (Pubitemid 26044470)
19. Gossl M, Modder UI, Atkinson EJ, et al. Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol 2008; 52: 1314-25.
20. Ohmori R, Momiyama Y, Taniguchi H, et al. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 2003; 170: 333-7. (Pubitemid 37377807)
21. Liaw L, Almeida M, Hart CE, et al. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 1994; 74: 214-24. (Pubitemid 24029153)
22. Standal T, Borset M, Sundan A. Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Exp Oncol 2004; 26: 179-84.
23. Waller AH, Sanchez-Ross M, Kaluski E, Klapholz M. Osteopontin in cardiovascular disease. A potential therapeutic target. Cardiol Rev 2010; 18: 125-31.
24. Venuraju SM, Yerramasu A, Corder R, Lahiri A. Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. J Am Coll Cardiol 2010; 55: 2049-61.
25. Arruda AM, Das MK, Roger VL, et al. Prognostic value of exercise echocardiography in 2,632 patients ≥ 65 years of age. J Am Coll Cardiol 2001; 37: 1036-41. (Pubitemid 32217603)
26. Peterson PN, Magid DJ, Ross C, et al. Association of exercise capacity on treadmill with future cardiac events in patients referred for exercise testing. Arch Intern Med 2008; 168: 174-9. (Pubitemid 351185884)
27. Pierre-Louis B, Aronow WS, Yoon JH, et al. Incidence of myocardial infarction or stroke or death at 47-month follow-up in patients with diabetes and a predicted exercise capacity less than 85% versus greater than 85% during an exercise treadmill sestamibi stress test. Preventive Cardiology 2010; 13: 14-7.
28. From AM, Hyder JA, Kearns AE, et al. Relationship between low bone mineral density and exercise-induced myocardial ischemia. Mayo Clin Proc 2007; 82: 679-85. (Pubitemid 46878090)
29. Greg EW, Cauley JA, Stone K, et al. Study of Osteoporotic Fractures Research Group. Relationship of changes in physical activity and mortality among older women. JAMA 2003; 289: 2379-86.
30. Chen JS, Cameron ID, Cumming RG, et al. Effect of age-related chronic immobility on markers of bone turnover. J Bone Miner Res 2006; 21: 324-31. (Pubitemid 43265299)
31. Abedin M, Tintut Y, Demer LL. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004; 24: 1161-70. (Pubitemid 38880003)
32. Pierre-Louis B, Aronow WS, Yoon JH, et al. Relation of bone mineral density to stress test-induced myocardial ischemia. Am J Cardiol 2009; 104: 199-201.
33. DeLuca AJ, Kaplan S, Aronow WS, et al. Comparison of prevalence of unrecognized myocardial infarction and of silent myocardial ischemia detected by a treadmill exercise sestamibi stress test in patients with versus without diabetes mellitus. Am J Cardiol 2006; 98: 1045-6. (Pubitemid 44486143)
34. Tanko LB, Christiansen C, Cox DA, et al. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 2005; 20: 1912-20. (Pubitemid 41532776)
35. Aksoy Y, Yagmur C, Tekin GO, et al. Aortic valve calcification: association with bone mineral density and cardiovascular risk factors. Coron Artery Dis 2005; 16: 379-83. (Pubitemid 41783042)
36. Jie KG, Bots ML, Vermeer C, et al. Vitamin K status and bone mass in women with and without aortic atherosclerosis: a population-based study. Calcif Tissue Int 1996; 59: 352-6. (Pubitemid 26367082)
37. Skolnick AH, Osranek M, Formica P, Kronzon I. Osteoporosis treatment and progression of aortic stenosis. Am J Cardiol 2009; 104: 122-4.
38. Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12: 1260-8. (Pubitemid 28213402)
39. Parhami F, Tintut Y, Beamer WG, et al. Atherogenic high-fat diet reduces bone mineralization in mice. JBMR 2001; 16: 182-8. (Pubitemid 32046204)
40. Solomon DH, Finkelstein JS, Wang P, Avorn J. Statin lipid-lowering drugs and bone mineral density. Pharmacoepidemiol Drug Saf 2005; 14: 219-26. (Pubitemid 40528851)
41. Bauer DC, Mundy GR, Jamal SA, et al. Use of statins and fracture. Results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials. Arch Intern Med 2004; 164: 146-52.
42. Pasco JA, kotowicz MA, Henry MJ, et al. Statin use, bone mineral density, and fracture risk. Arch Intern Med 2002; 162: 537-40.
43. Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78-81. (Pubitemid 27130923)
44. Shiraki M, Shiraki Y, Aoki C, et al. Association of bone mineral density with apolipoprotein E phenotype. J Bone Min Res 1997; 12: 1438-45. (Pubitemid 27375387)
45. Cauley JA, Zmuda JM, Yaffe K, et al. Apolipoprotein E polymorphism : a new genetic marker of hip fracture risk - The Study of Osteoporotic Fractures. J Bone Min Res 1999; 14: 1175-81. (Pubitemid 29314061)